[Chemotherapy of head and neck carcinomas. Association of adriamycine, vincristine and methotrexate (author's transl)].
Phase II of a study of chemotherapy using adriamycine, vincristine and methotrexate is reported. Forty-six patients with carcinoma of the head and neck were treated; thirty-eight of these results can be evaluated. The degree of objective response is mainly influenced by the site of the tumour. It can vary from 8/23 to twice that figure 16/23 depending on whether the tumour is located in the territory which was previously irradiated. The mean duration of response is short, 2,5 months. The treatment seems to be quite toxic.